Aditya D. Joshi, Ph.D.

Assistant Professor

Pharmaceutical Sciences

Phone 405-271-6593 x 47471

Fax 405-271-7505

Email aditya-joshi@ouhsc.edu

Faculty Website www.joshilaboratory.org


Summary

My research is focused on understanding Aryl hydrocarbon Receptor (AhR) signaling in normal liver physiology as well as in plethora of hepatic and metabolic diseases. The AhR is a ligand-activated transcription factor, historically studied in the context of exogenous ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) induced toxicity. We have demonstrated that in contrast to the toxicity exhibited by exogenous AhR agonists, the endogenous AhR ligand, cinnabarinic acid induced expression of AhR target gene, stanniocalcin 2 is responsible for hepatoprotection against chemical, environmental and pharmacological stressors both in vitro and in vivo. Our long-term objectives are to mechanistically study repertoire of AhR target genes in the context of liver and metabolic diseases and to develop a translational approach to AhR biology by identifying and characterizing therapeutically useful endogenous AhR agonists to ameliorate hepatic injury. To achieve our long-term goal my research employs cutting-edge cellular, molecular and biochemical methodologies as well as utilizes innovative genome-wide technologies such as next-generation sequencing (RNA, ChIP and ATAC-seq) and CRISPR mediated genome editing. 




Publications & Presentations

1 2 3 4 > >>
    1. Eeda V, Patil N Y, Joshi A, Awasthi V, Eeda V, Jain D. Advancements in metabolic-associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions. Hepatology Research. 2023

    2. Patil N, Rus I, Joshi A. Role of ERK1/2 Signaling in Cinnabarinic Acid-Driven Stanniocalcin 2-Mediated Protection against Alcohol-Induced Apoptosis. Journal of Pharmacology and Experimental Therapeutics. In Press; 387 : 111-120

    3. Patil N Y, Friedman J E, Joshi A D. Role of Hepatic Aryl Hydrocarbon Receptor in Non-Alcoholic Fatty Liver Disease. Receptors. In Press; 2 : 1-15

    4. Patil N Y, Rus I, Downing E, Mandala A, Friedman J E, Joshi A D. Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease. Journal of Pharmacology and Experimental Therapeutics. In Press; 383 : 32-43

    5. Joshi A D, Thinakaran G, Elferink C. Cinnabarinic acid-induced stanniocalcin 2 confers cytoprotection against alcohol-induced liver injury. Journal of Pharmacology and Experimental Therapeutics. 2022; 381 : 1-11

1 2 3 4 > >>



Grants


no results

Awards and Honors

1 2 >>
                                                                                            1. Society of Toxicology. Mechanism Specialty Section Research Award. Date: 2015.  

                                                                                            2. Society of Toxicology. Molecular and Systems Biology Specialty Section Research Award. Date: 2015.  

                                                                                            3. Society of Toxicology. Dr. Dharm Singh Award. Date: 2013.  

                                                                                            4. Society of Toxicology. Molecular Biology Specialty Section Research Award. Date: 2013.  

                                                                                            5. University of Texas Medical Branch. Mason Guest Award in Physiology and Biophysics . Date: 2006.  

1 2 >>



Education

                                                                                            1.  Degree: Ph D. University of Texas Medical Branch. Date: 2008.  

                                                                                            2.  Degree: MS. University of Mumbai. Date: 2002.  

                                                                                            3.  Degree: BS. University of Mumbai. Date: 2000.